Covestor’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80K | Buy |
4,600
+605
| +15% | +$10.5K | 0.05% | 672 |
|
|
2025
Q1 | $87K | Buy |
3,995
+3
| +0.1% | +$65 | 0.06% | 569 |
|
|
2024
Q4 | $127K | Buy |
3,992
+3,784
| +1,819% | +$120K | 0.08% | 365 |
|
|
2024
Q3 | $6K | Buy |
208
+1
| +0.5% | +$29 | ﹤0.01% | 1703 |
|
|
2024
Q2 | $8K | Buy |
207
+1
| +0.5% | +$39 | 0.01% | 1652 |
|
|
2024
Q1 | $12K | Sell |
206
-1
| -0.5% | -$58 | 0.01% | 1418 |
|
|
2023
Q4 | $12K | Sell |
207
-590
| -74% | -$34.2K | 0.01% | 1409 |
|
|
2023
Q3 | $30K | Buy |
797
+677
| +564% | +$25.5K | 0.02% | 973 |
|
|
2023
Q2 | $11K | Sell |
120
-49
| -29% | -$4.49K | 0.01% | 1376 |
|
|
2023
Q1 | $11K | Hold |
169
| – | – | 0.01% | 1250 |
|
|
2022
Q4 | $9K | Sell |
169
-8
| -5% | -$426 | 0.01% | 1356 |
|
|
2022
Q3 | $12K | Sell |
177
-98
| -36% | -$6.64K | 0.01% | 1176 |
|
|
2022
Q2 | $12K | Sell |
275
-1
| -0.4% | -$44 | 0.01% | 1127 |
|
|
2022
Q1 | $14K | Buy |
276
+257
| +1,353% | +$13K | 0.01% | 1169 |
|
|
2021
Q4 | $1K | Buy |
+19
| New | +$1K | ﹤0.01% | 1625 |
|